2002
DOI: 10.4049/jimmunol.168.7.3667
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction

Abstract: We demonstrated the presence of circulating Abs from schizophrenic patients able to interact with cerebral frontal cortex-activating muscarinic acetylcholine receptors (mAChR). Sera and purified IgG from 21 paranoid schizophrenic and 25 age-matched normal subjects were studied by indirect immunofluorescence, flow cytometry, immunoblotting, dot blot, ELISA, and radioligand competition assays. Rat cerebral frontal cortex membranes and/or a synthetic peptide, with an amino acid sequence identical with that of hum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(49 citation statements)
references
References 47 publications
2
47
0
Order By: Relevance
“…193,194 These antibodies are functionally active as they activate muscarinic receptors on astrocytes 195 and induce an increase in M 1 muscarinic receptor mRNA. 196 These findings, while still preliminary, suggest an interesting possible link between the immune system and muscarinic receptors in schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…193,194 These antibodies are functionally active as they activate muscarinic receptors on astrocytes 195 and induce an increase in M 1 muscarinic receptor mRNA. 196 These findings, while still preliminary, suggest an interesting possible link between the immune system and muscarinic receptors in schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…These antibodies displace tritiated pirenzapine and have agonist-like properties at the M1 receptor in in vitro assays (Borda et al, 2002).…”
Section: A Deficits In Components Of Muscarinic Cholinergic Transmismentioning
confidence: 99%
“…32 Accordingly, it has been considered that disease-associated autoantibodies may emerge from the natural autoantibody repertoire. 33 In this context, characterization of agonistic anti-G protein-coupled receptor autoantibodies in several pathologic conditions, including Graves disease, 34 preeclampsia, 35 neonatal lupus congenital heart block, 36 and schizophrenia, 37 may presume that these kinds of autoantibodies, including anti-hMOR autoantibodies, are a common feature of the natural autoantibody repertoire.…”
Section: Discussionmentioning
confidence: 99%